In last trading session, Viking Therapeutics Inc (NASDAQ:VKTX) saw 5.36 million shares changing hands with its beta currently measuring 0.63. Company’s recent per share price level of $28.17 trading at $1.08 or 3.99% at ring of the bell on the day assigns it a market valuation of $3.16B. That closing price of VKTX’s stock is at a discount of -190.13% from its 52-week high price of $81.73 and is indicating a premium of 32.84% from its 52-week low price of $18.92. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 3.99 million shares which gives us an average trading volume of 3.81 million if we extend that period to 3-months.
For Viking Therapeutics Inc (VKTX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.21. Splitting up the data highlights that, out of 7 analysts covering the stock, 0 rated the stock as a Sell while 1 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Viking Therapeutics Inc (NASDAQ:VKTX) trade information
Upright in the green during last session for gaining 3.99%, in the last five days VKTX remained trading in the green while hitting it’s week-highest on Thursday, 06/26/25 when the stock touched $28.17 price level, adding 2.36% to its value on the day. Viking Therapeutics Inc’s shares saw a change of -45.95% in year-to-date performance and have moved 7.19% in past 5-day. Viking Therapeutics Inc (NASDAQ:VKTX) showed a performance of 3.64% in past 30-days. Number of shares sold short was 28.47 million shares which calculate 9.61 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 75 to the stock, which implies a rise of 62.44% to its current value. Analysts have been projecting 75 as a low price target for the stock while placing it at a high target of 75. It follows that stock’s current price would drop -166.24% in reaching the projected high whereas dropping to the targeted low would mean a loss of -166.24% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -23.00% during past 5 years.
Viking Therapeutics Inc (NASDAQ:VKTX)’s Major holders
Insiders are in possession of 2.12% of company’s total shares while institution are holding 70.04 percent of that, with stock having share float percentage of 71.56%. Investors also watch the number of corporate investors in a company very closely, which is 70.04% institutions for Viking Therapeutics Inc that are currently holding shares of the company. FMR LLC is the top institutional holder at VKTX for having 16.54 million shares of worth $876.8 million. And as of 2024-06-30, it was holding 14.9835 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 10.1 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.147 of outstanding shares, having a total worth of $535.26 million.
